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Purpose
Kampo (Japanese traditional herbal medicine) plays a
certain role in the current health practices in Japan.
Similar to other medical interventions, health-economic
aspects of Kampo medicines should be assessed for the
rational use of scarce healthcare resources. The purpose
of this study is to review the published pharmacoeco-
nomic evaluations on Kampo medicines in Japan, deli-
neating the current situation in this area.
Methods
We searched the database “Ichushi (Japana Centra
Revuo Medicina) Web (Ver.5)” which is the largest data-
base of medical literature in Japan, using search terms of
“Kampo” and “keizai” (economics). Literature published
between 1983 and 2011 were eligible for searching.
After primary screening, we selected articles regarded as
full economic evaluations or cost studies. Structured
abstracts designed especially for health-economic ana-
lyses of Kampo medicines were composed for them.
Results
Although we found 110 articles via initial electric search,
only 11 articles on Kampo medicines (10 full economic
evaluations and 1 cost analysis) were eligible for next
phase, i.e., composing a structured abstract. The most
common design of full economic evaluations is cost-
consequence analysis (CCA) (n=8), which did not aggre-
gate costs and consequences in the conclusions. How-
ever, considering the measurement of consequences
adopted in those CCAs, 6 evaluations were similar to
cost-effectiveness analysis (CEA) and the other 2 were
similar to cost-minimization analysis (CMA). No cost-
utility analyses (CUA) were found in our review.
Conclusion
The published pharmacoeconomic evaluations on
Kampo medicines in Japan are few and the quality of
them needs to be improved. The spread of essential
pharmacoeconomic knowledge among researchers is
considered to be important for the future economic eva-
luations on Kampo medicines and its use in health pol-
icy and practices in Japan.
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